Keating, CR; Calvisi, DF; Qiu, WHigh-fat diet-induced AKT-palmitoylation in hepatocellular carcinoma: a breakthrough mechanistic investigation. Gut;
Hou, W; Gad, SA; Ding, X; Dhanarajan, A; Qiu, WFocal adhesion kinase confers lenvatinib resistance in hepatocellular carcinoma via the regulation of lysine-deficient kinase 1. Molecular carcinogenesis;
Buttell, A; Qiu, WThe action and resistance mechanisms of Lenvatinib in liver cancer. Molecular carcinogenesis;
Malnassy, G; Keating, CR; Gad, S; Bridgeman, B; Perera, A; Hou, W; Cotler, SJ; Ding, X; Choudhry, M; Sun, Z; Koleske, AJ; Qiu, WInhibition of Abelson Tyrosine-Protein Kinase 2 Suppresses the Development of Alcohol-Associated Liver Disease by Decreasing PPARgamma Expression. Cellular and molecular gastroenterology and hepatology;
Liu, X; Khalafalla, M; Chung, C; Gindin, Y; Hubchak, S; LeCuyer, B; Kriegermeier, A; Zhang, D; Qiu, W; Ding, X; Fang, D; Green, RHepatic Deletion of X-box Binding Protein 1 in Farnesoid X Receptor Null Mice Leads to Enhanced Liver Injury. Journal of lipid research;
Qiu, W; Hou, WIntegrin subunit beta 8 contributes to lenvatinib resistance in liver cancer. FASEB journal : official publication of the Federation of American Societies for Experimental Biology; 36 Suppl 1
Yunru Chen Qing Li Kangsheng Tu Yuanguo Wang Xianghu Wang Dandan Liu Chen Chen Donglian Liu Rendong Yang Wei Qiu Ningling KangFocal Adhesion Kinase Promotes Hepatic Stellate Cell Activation by Regulating Plasma Membrane Localization of TGFß Receptor 2 HEPATOLOGY COMMUNICATION; 268-283
1. Shang N, Wang H, Bank T, Perera A, Joyce C, Kuffel G, Michael Z, Cotler S, Ding XZ, Dhanarajan A, Breslin P, Qiu WFocal adhesion kinase and ß-catenin cooperate to induce hepatocellular carcinoma HEPATOLOGY;
Qiu WReply to "FAK/CAT network may act as a regulator of HCC epigenetics" Hepatology (Baltimore, Md.);
Wang F, Bank T, Malnassy G, Arteaga M, Shang N, Dalheim A, Ding X, Cotler SJ, Denning MF, Nishimura MI, Breslin P, Qiu WInhibition of insulin-like growth factor 1 receptor enhances the efficacy of sorafenib in inhibiting hepatocellular carcinoma cell growth and survival. Hepatology communications; 2 6 732-746
Shang, N; Bank, T; Ding, X; Breslin, P; Li, J; Shi, B; Qiu, WCaspase-3 suppresses diethylnitrosamine-induced hepatocyte death, compensatory proliferation and hepatocarcinogenesis through inhibiting p38 activation. Cell death & disease; 9 5
Chitsike L, Ding, XZ, Breslin P, Qiu WABL1 is overexpressed and activated in hepatocellular carcinoma JOURNAL OF CANCER AND TUMOR INTERNATIONAL; 6 3 1-8
Shang, N., Arteaga, M., Zaidi, A., Cotler, S.J., Breslin, P., Ding, X.Z., Kuo, P., Nishimura, M., Zhang, J., Qiu, W.FAK kinase activity is required for the progression of c-Met/ß-catenin-driven HCC GENE EXPRESSION: THE JOURNAL OF BASIC LIVER RESEARCH.; 17 1 79-88
Arteaga, M., Shang, N., Ding, X.Z., Yong, S., Cotler, S.J., Denning, M.F., Shimamura, T., Breslin, P., Bernhard, L., Qiu, W.Inhibition of SIRT2 suppresses hepatic fibrosis. AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY; 310 11 G1155-68